Publication | Open Access

Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations

Peptide AnaloguesMedicinePharmacologyImmunologyAntiviral ResponseVirologyAntiviral Drug DevelopmentAntiviral TherapySpike GlycoproteinViral Structural ProteinAntiviral DrugMolecular DockingDrug Discovery